Edit |   |
---|---|
Antigenic Specificity | CD27, Human (Varlilumab biosimilar) |
Clone | Varlilumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG1 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | n/a |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human CD27 Recombinant Antibody. Varlilumab (INN, development code CDX-1127) is a monoclonal antibody designed for immunotherapy for solid tumors and hematologic malignancies. It is an anti-CD27 antibody and helps activate T-cells. This drug was developed by Celldex Therapeutics. |
Immunogen | n/a |
Other Names | Anti-CD27 Recombinant Antibody, Research Grade Varlilumab, Anti-Human CD27 Recombinant Antibody, 1F5, CDX-1127, Antibody Drug Analogues, Monoclonal Antibody, YR1338, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1393344-72-3 |
Catalog # | YR1338 |
Price | please inquire |
Order / More Info | CD27, Human (Varlilumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |